Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MEMO1 pseudogene 3 (MEMO1P3) is a processed pseudogene of the MEMO1 gene located in the human genome. Unlike the protein-coding MEMO1 gene (Mediator of cell motility 1), MEMO1P3 does not encode a functional protein and is not believed to participate directly in cellular signaling pathways. Pseudogenes may have regulatory functions, such as acting as competing endogenous RNAs (ceRNAs) that modulate the availability of microRNAs for other transcripts, but there are no specific reports of MEMO1P3 having such activity. MEMO1P3 is therefore not considered a relevant therapeutic target, enzyme, transporter, or receptor, nor is it implicated as a biomarker or in drug interactions. Its main clinical or biological significance remains undefined, and it is primarily annotated as a non-functional genomic element.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MEMO1 pseudogene 3 (MEMO1P3).